Skip to content

DDDelegation Decoded

States Ask Races Compare Journalists About

DD

A public-records guide to Congress and the 2026 midterms

States Ask Find mine Compare For journalists Health About & Methodology

Data from @unitedstates, Congress.gov, FEC, House Clerk, and Senate eFD. For journalism and public-records purposes. Not affiliated with the U.S. government.

Built by Trevor Brown

Source code Report a bug Contact

Home/Bill/HR 679

HR 679 · 119th Congress

To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

Introduced Jan 23, 2025Last action Jan 23, 2025· HealthCongress.gov →

Latest action

Referred to the House Committee on Energy and Commerce.

Sponsor

Diana HarshbargerRepublican · TN-1Profile →

Cosponsors (18)

18 R

Brian BabinTX-36Jan 23, 2025
James R. BairdIN-4Jan 23, 2025
Sheri BiggsSC-3Mar 31, 2025
Andy BiggsAZ-5Jan 23, 2025
Mike BostIL-12Jan 23, 2025
Randy FeenstraIA-4Jan 23, 2025
Michael GuestMS-3Jan 23, 2025
Andy HarrisMD-1Jan 28, 2025
Kevin HernOK-1Jan 23, 2025
Clay HigginsLA-3Jan 23, 2025
Mark B. MessmerIN-8Feb 4, 2026
Mary E. MillerIL-15Jan 23, 2025
John R. MoolenaarMI-2Jan 23, 2025
Gary J. PalmerAL-6Jan 23, 2025
Keith SelfTX-3Feb 4, 2025
Randy K. Weber, Sr.TX-14Jan 23, 2025
Daniel WebsterFL-11Jan 23, 2025
Rudy Yakym IIIIN-2Jan 23, 2025